ALT 0.00% 0.5¢ analytica limited

Strategic Review - Urgently Required, page-7

  1. 4,725 Posts.
    lightbulb Created with Sketch. 253
    Clinical trials are meant to be expensive.

    I'm presuming you mean clinical trials from the data being gathered.

    Which given there is only 1000 units out there, is not going to be very much is it.

    Hence why I'm suggesting loss leading the product for 6 months to get significant units out there generating a meaningful amount of data for the trial to be based on.

    Having a take up rate of 2 units a day after all this time is just a joke.

    No wonder they've never done monthly sales figures....................

    It would look like this.............

    We are pleased to report sales for October 2015 of 50 units

    We are pleased to report sales for November 2015 of 60 units ( a 20% MoM increase)

    We are pleased to report sales for December 2015 of 78 units ( a 30% MoM increase)

    LOTM
 
watchlist Created with Sketch. Add ALT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.